Cannabis Law Report

APRIL 21, 2022

The availability of larger quantities of cGMP-compliant MDMA will facilitate ongoing clinical trials and provide for future therapeutic use following anticipated regulatory approvals. Publication of this process establishes “prior art,” contributing to MAPS’ patient access strategy by making intellectual property public .

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

Cannabis Law Report

JULY 1, 2021

Clinical trials repeatedly demonstrate their promise for treating mood, anxiety, and substance use disorders. POPLAR is the first academic initiative focused on psychedelics law and policy, positioned to be a global leader for research and education in this space. Background. The Project.

Law 59

Law Policy Research and Development Clinical Trials 59

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. MAPS completed the first Phase 1 safety study with MDMA and resumed working on a protocol for anxiety associated with cancer.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

TheAnswerPage

JANUARY 11, 2022

As the Editor-in-Chief of the medical education website called TheAnswerPage.com for nearly two decades, I have assessed multiple educational gaps in the healthcare community. Thus, an educational gap developed, creating a less than ideal situation for medical marijuana patients. So, why did this educational gap develop?

Patients 98

Patients Education Marijuana Therapy 98

SpeedWeed

JULY 6, 2021

The Project on Psychedelics Law and Regulation (POPLAR) is a three-year project aiming to “promote safety, innovation, and equity in psychedelics research, commerce, and therapeutics,” the university said in a press release. Professor of Law at Harvard Law School. “By

Policy 52

Policy Law Research and Development Therapy 52

Cannabis Law Report

JULY 28, 2021

We believe in diversity and inclusion of people of all backgrounds, genders, races, ethnicities, sexual orientations, educational backgrounds, military and veteran status,?religions, MAPS PBC strives to continually improve upon the supportive, equitable and accessible work environment. Experience working for a clinical study Sponsor.

Clinical Trials 105

Clinical Trials Research and Development Data Environment 105

Veriheal

AUGUST 31, 2020

At Veriheal, education and diversity are at the center of our core values. Choosing only 10 winners for the $10,000 in scholarships among the strong applications we received from multiple disciplines and concentrations in higher education—from students of all backgrounds and interests—was extremely difficult.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

AUGUST 21, 2019

However, health professionals have been reluctant to prescribe cannabis-based medicines in the UK because of the lack of clinical trial evidence of its benefits and safety. This would answer questions about safety and efficacy, they said. The final guideline is expected to be published in November 2019.

Clinical Trials 81

Clinical Trials Nerve Pain Medicine Epilepsy 81

Cannabis Law Report

JULY 21, 2022

The comprehensive legislation would end federal cannabis prohibition by removing cannabis from the Controlled Substances Act; empower states to create their own cannabis laws; ensure federal regulation protects public health and safety; and prioritize restorative and economic justice .

Safety 52

Safety Legislation Clinical Trials Banking 52

The Cannigma

AUGUST 26, 2021

The country legalized medical cannabis in 2016, but patients in the country have long criticized the program as too restrictive, and access to cannabis-based medicines remains behind that of many other legal cannabis jurisdictions. This also means that the TGA has not accessed these medicines for their safety, quality, or effectiveness.

Legalization 52

Legalization Access Medicine Clinical Trials 52

Cannabis Law Report

DECEMBER 7, 2021

Our audacious mission is to create the new standard of trust and transparency consumers deserve and healthcare providers demand on these widely accessible potential therapies. The large scale and intentional heterogeneity of our studies can transform these consumer health products into democratized precision solutions.”.

Clinical Trials 52

Clinical Trials CBD Data Sleep 52

Peninsula Alternative Health

MAY 15, 2019

The huge difference between medical cannabis and traditional pharmaceuticals is that cannabis is quickly becoming accessible to treat conditions before clinical trials and standard dosing protocols have been established. This cannot be said for most if any prescribed or over the counter medicines on today's market.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Cannabis Law Report

AUGUST 19, 2019

Access to medicinal cannabis for patients was legalised in Australia in 2016, allowing doctors to request permission to prescribe from the Australian government. This is at least due to the difficulty and cost involved in accessing a legal prescription. Patient access pathways.

Medicine 45

Medicine Patients Clinical Trials Access 45

Cannabis Law Report

DECEMBER 2, 2021

Under the approved recommendations, students applying for psilocybin training programs are required to provide a description of their educational background and a written statement explaining their commitment and interest in becoming a psilocybin facilitator. Safety, Ethics and Responsibilities of a Psilocybin Facilitator (10 Hours).

Law 52

Law Programs Therapy Education 52

Cannabis Law Report

JANUARY 14, 2020

CLICK IMAGE TO ACCESS COMMITTEE INFO PAGE. Additionally, it would open up medical marijuana policies with “directives to conduct research on the impact of marijuana on the brain, the efficacy of medical marijuana, identification of additional medical benefits and uses of cannabis, and support highway safety research.”. Legislation.

Clinical Trials 69

Clinical Trials Programs Access DEA 69

Project CBD

NOVEMBER 11, 2023

So just on safety alone, it’s worth using it. We rate levels of evidence, and a high level may be a controlled randomized clinical trial (RCT), but there are also observational studies. states there are dispensaries where most people have access to cannabis drugs. Yeah, I think education information is key.

Medicine 301

Medicine Research and Development Pharmaceutical Cannabis 301

CannaMD

MARCH 8, 2021

Read on to learn why CannaMD is leading the charge with other physician groups to educate legislators and oppose H.B. 1455 covers three major themes: medical marijuana advertising, THC potency/access to high-THC products, and administrative issues. 1455 – and how YOU can fight back with research-based arguments! Florida H.B.

THC 116

THC Research and Development Treatment Patients 116

The Cannigma

MARCH 12, 2021

At the end of the episode, Debbie Churgai, executive director of Americans for Safe Access, discusses the various ways that military veterans — who could very much benefit from medical cannabis — have difficulty accessing it and the ways that the Veterans Administration can address that issue. Produced by Michael Schaeffer Omer-Man.

Legalization 128

Legalization Patients Education Dispensary 128

Peninsula Alternative Health

MAY 15, 2019

The huge difference between medical cannabis and traditional pharmaceuticals is that cannabis is quickly becoming accessible to treat conditions before clinical trials and standard dosing protocols have been established. This cannot be said for most if any prescribed or over the counter medicines on today's market.

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. The review, however, did not cover patient access to medicinal cannabis. Refractory paediatric epilepsy.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

MAY 13, 2019

In nearly every jurisdiction where medicinal cannabis is legal, at least one medical professional is required to sign off for a person to access it. The number of jurisdictions allowing access to medicinal cannabis has been steadily increasing since the state of California introduced legislation in 1996. Gardiner , Judith A.

Medicine 45

Medicine Research and Development Clinical Trials Data 45

The Cannigma

DECEMBER 22, 2021

The Cannabis Enigma is a co-production of The Cannigma and Americans for Safe Access. We’ve got our regular segment with Americans for Safe Access. We do participate in clinical trials that are initiated by others, and we will have our own clinical trial using terpene formulations in oil.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

The Cannigma

APRIL 8, 2021

With cannabis, Dr. Peterson, continues, your best source of education is often a budtender with nothing more than a high school education. The Cannabis Enigma is a co-production of The Cannigma and Americans for Safe Access. They can only refer you, and then you get sent to someone with potentially just a high school education.

Medicine 108

Medicine Cannabinoids Cannabis THC 108

The Cannigma

JUNE 15, 2021

For now, if you have access to quality CBD products, there’s no reason to prioritize CBG products. Easy access. But the main issue with hemp derived products and their safety is less about the CBD and more about everything else in them. However, the scientific data on CBG is nowhere near as developed as what we have on CBD.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

JUNE 4, 2021

Through his social media outlets, podcast, blog, and interviews, Tim has educated hundreds of millions of people about psychedelics. Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51